NCT07553572 Remote Monitoring and Symptom Management Digital Application
| NCT ID | NCT07553572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Patrick C. Johnson, MD |
| Condition | Breast Cancer (Locally Advanced or Metastatic) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-14 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-14 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment. The main question\[s\] it aims to answer are: Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)? Researchers will compare the ASSIST phone application to see how it compares to usual clinical care. Participants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 years or older 2. Ability to understand English 3. About to begin definitive systemic treatment (or within 4 weeks of beginning treatment) based upon the oncology treatment intent form for a new diagnosis of breast cancer, colorectal cancer, or lymphoma. 4. Expected treatment duration of at least 12 weeks 5. Own or willing to receive a smartphone Exclusion Criteria: 1. Cognitive impairment that would interfere with ability to use smartphone application (as assessed by their attending physician) 2. Visual or motor impairment that would prevent smartphone use 3. Expected survival less than 3 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07553572 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer (Locally Advanced or Metastatic). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07553572 currently recruiting?
Yes, NCT07553572 is actively recruiting participants. Contact the research team at pcjohnson@mgh.harvard.edu for enrollment information.
Where is the NCT07553572 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07553572 clinical trial?
NCT07553572 is sponsored by Patrick C. Johnson, MD. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.